Frédéric Jung

1.5k citations

28 papers · 860 · h-index 15

Impact in

Cell Biology top 5%
- Microtubule and mitosis dynamics
Oncology top 10%
- Cancer-related Molecular Pathways

Papers in

Organic Chemistry 16
- Synthesis of β-Lactam Compounds 4
- Organic Chemistry Cycloaddition Reactions 3
- Synthesis and Reactions of Organic Compounds 3
- Quinazolinone synthesis and applications 2
Molecular Biology 10
- Chemical Synthesis and Analysis 4

Co-authors: Nicola M. Heron (6 shared papers)Andrew Mortlock (6 shared papers)Stephen Green (6 shared papers)Robert W. Wilkinson (5 shared papers)Nicholas Keen (5 shared papers)Kevin M. Foote (5 shared papers)Tony Durst (4 shared papers)Stephen R. Wedge (3 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (6 papers)Tetrahedron Letters (5 papers)Tetrahedron (2 papers)Journal of the American Chemical Society (2 papers)Current Topics in Medicinal Chemistry (2 papers)
Partner nations: France United Kingdom United States

In The Last Decade

Frédéric Jung

27 papers receiving 824 citations

Peers

Countries citing papers authored by Frédéric Jung

Since Specialization

Citations

This map shows the geographic impact of Frédéric Jung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Jung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Jung more than expected).

Fields of papers citing papers by Frédéric Jung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Jung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Jung. The network helps show where Frédéric Jung may publish in the future.

Co-authors

The 25 scholars most cited alongside Frédéric Jung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Frédéric Jung Line = papers co-authored together Frédéric Jung links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	AZD1152, a Selective Inhibitor of Aurora B Kinase, Inhibits Human Tumor Xenograft Growth by Inducing Apoptosis Clinical Cancer Research ·Robert W. Wilkinson, Rajesh Odedra, Simon P. Heaton, Stephen R. Wedge, Nicholas Keen, Claire Crafter, John R. Foster, Madeleine C. Brady, Alison Bigley, Elaine Brown, Kate F. Byth, Nigel Barrass, Kirsten Mundt, Kevin M. Foote, Nicola M. Heron, Frédéric Jung, Andrew Mortlock, F. Thomas Boyle, Stephen Green	2007	281
2	SAR and inhibitor complex structure determination of a novel class of potent and specific Aurora kinase inhibitors Bioorganic & Medicinal Chemistry Letters ·Nicola M. Heron, Malcolm Anderson, David P. Blowers, J. Breed, Jonathan Eden, Stephen Green, George B. Hill, Trevor Johnson, Frédéric Jung, Helen McMiken, Andrew Mortlock, Andrew Pannifer, Richard A. Pauptit, Jennifer H. Pink, Nicola Roberts, Siân Rowsell	2005	101
3	Progress in the Development of Selective Inhibitors of Aurora Kinases Current Topics in Medicinal Chemistry ·Andrew Mortlock, Nicholas Keen, Frédéric Jung, Nicola M. Heron, Kevin M. Foote, Robert W. Wilkinson, Stephen Green	2005	62
4	Discovery of AZD2932, a new Quinazoline Ether Inhibitor with high affinity for VEGFR-2 and PDGFR tyrosine kinases Bioorganic & Medicinal Chemistry Letters ·Patrick A. Plé, Frédéric Jung, Sue Ashton, Laurent Hennequin, Romuald Lainé, Rémy Morgentin, Georges Pasquet, Sian Taylor	2011	46
5	Discovery of novel imidazo[1,2-a]pyridines as inhibitors of the insulin-like growth factor-1 receptor tyrosine kinase Bioorganic & Medicinal Chemistry Letters ·Richard Ducray, Iain Simpson, Frédéric Jung, J. Willem M. Nissink, Peter W. Kenny, Martina Fitzek, Graeme E. Walker, Lara Ward, Kevin Hudson	2011	44
6	Decomposition of 3,6-dihydro-1,2-oxathiin 2-oxides to sulfur dioxide and 1,3-dienes. A .pi.4s+.pi.2s cycloreversion Journal of the American Chemical Society ·Frédéric Jung, Marta Dal Molin, R. Van der Elzen, Tony Durst	1974	44
7	Novel imidazo[1,2-a]pyridine based inhibitors of the IGF-1 receptor tyrosine kinase: Optimization of the aniline Bioorganic & Medicinal Chemistry Letters ·Richard Ducray, Clifford D. Jones, Frédéric Jung, Iain Simpson, Jon Curwen, Martin Pass	2011	36
8	.beta.-Sultines. Intermediates in a sulfur analog of the Wittig olefin synthesis Journal of the American Chemical Society ·Frédéric Jung, N. K. SHARMA, Tony Durst	1973	36
9	Synthesis and SAR of 1-acetanilide-4-aminopyrazole-substituted quinazolines: Selective inhibitors of Aurora B kinase with potent anti-tumor activity Bioorganic & Medicinal Chemistry Letters ·Kevin M. Foote, Andrew Mortlock, Nicola M. Heron, Frédéric Jung, George B. Hill, Georges Pasquet, Madeleine C. Brady, Stephen Green, Simon P. Heaton, Sarah Kearney, Nicholas Keen, Rajesh Odedra, Stephen R. Wedge, Robert W. Wilkinson	2008	32
10	Progress in the Development of Selective Inhibitors of Aurora Kinases Current Topics in Medicinal Chemistry ·Andrew Mortlock, Nicholas Keen, Frédéric Jung, Nicola M. Heron, Kevin M. Foote, Robert W. Wilkinson, Stephen Green	2005	20
11	Synthesis of 3-fluoro azetidinone by electrophilic fluorination Tetrahedron Letters ·Jean‐Pierre Genêt, Jean‐Olivier Durand, Sylvain Roland, Monique Savignac, Frédéric Jung	1997	19
12	An efficient large-scale synthesis of alkyl 5-hydroxy-pyridin- and pyrimidin-2-yl acetate Tetrahedron ·Rémy Morgentin, Frédéric Jung, Maryannick Lamorlette, Mickaël Maudet, Morgan Ménard, Patrick A. Plé, Georges Pasquet, Fabrice G. Renaud	2008	17
13	Synthesis and structure-activity relationship of new cephalosporins with amino heterocycles at C-7. Dependence of the antibacterial spectrum and .beta.-lactamase stability on the pKa of the C-7 heterocycle Journal of Medicinal Chemistry ·Frédéric Jung, Christian Delvare, D. Boucherot, A. Hamon, N. Ackerley, Michael J Betts	1991	16
14	Strategic studies in the syntheses of novel 6,7-substituted quinolones and 7- or 6-substituted 1,6- and 1,7-naphthyridones Tetrahedron ·Rémy Morgentin, Georges Pasquet, Pascal Boutron, Frédéric Jung, Maryannick Lamorlette, Mickaël Maudet, Patrick A. Plé	2008	15
15	π-Allyl palladium ring closure strategy for the synthesis of a 1β-methylcarbapenem intermediate Tetrahedron Letters ·Sylvain Roland, J.O. Durand, Monique Savignac, J. P. GENET, Frédéric Jung	1995	14
16	Synthesis and structure-activity relationships of new cephalosporins with aminoimidazoles at C-7. Effect of the pKa of the C-7 aminoimidazole on antibacterial spectrum and .BETA.-lactamase stability. The Journal of Antibiotics ·Frédéric Jung, D. Boucherot, Christian Delvare, A. Olivier, Gareth M. Davies, Michael J Betts, Randi L. Brown, Richard J. Stevenson, Mejo Joseph, John F. Kingston, John D. Pittam	1993	12
17	Diversity-orientated synthesis of 3,5-bis(arylamino)pyrazoles Tetrahedron Letters ·Sébastien L. Degorce, Frédéric Jung, Craig S. Harris, Patrice Koza, Jonathan Lecoq, Arnaud Stévenin	2011	12
18	A novel series of non-nucleoside inhibitors of inosine 5′-monophosphate dehydrogenase with immunosuppressive activity§§Abbreviations: β, coefficient of interaction; DTH, delayed-type hypersensitivity; FBS, foetal bovine serum; IMP, inosine 5′-monophosphate; IMPDH, IMP dehydrogenase; K′i, apparent inhibition constant for compound I; Kii, inhibition constant for effect on intercept of Lineweaver–Burk plots; K′x, apparent inhibition constant for compound X; MFT, mycophenolate mofetil; MTT, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; MPA, mycophenolic acid; TCA, trichloroacteic acid (10% w/v); v, velocity; v0, uninhibited velocity; and XMP, xanthosine monophosphate. Biochemical Pharmacology ·Trevor J Franklin, William P. Morris, Vivien N. Jacobs, Eric J Culbert, Christine A Heys, Walter H.J. Ward, Peter N. Cook, Frédéric Jung, Patrick A. Plé	1999	10
19	Discovery of new quinoline ether inhibitors with high affinity and selectivity for PDGFR tyrosine kinases Bioorganic & Medicinal Chemistry Letters ·Patrick A. Plé, Frédéric Jung, Sue Ashton, Laurent Hennequin, Romuald Lainé, Christine Lambert‐van der Brempt, Rémy Morgentin, Georges Pasquet, Sian Taylor	2012	8
20	A new approach to the synthesis of amino imidazoles application to the cephalosporin series Tetrahedron Letters ·Frédéric Jung, A. Olivier, D. Boucherot, F. Loftus	1989	8

About Frédéric Jung

Frédéric Jung is a scholar working on Organic Chemistry, Molecular Biology, Oncology, Cell Biology and Pharmaceutical Science, having authored 28 papers that have together received 860 indexed citations. Recurring topics across this work include Microtubule and mitosis dynamics (6 papers), Cancer-related Molecular Pathways (5 papers), Chemical Synthesis and Analysis (4 papers), Synthesis of β-Lactam Compounds (4 papers), Organic Chemistry Cycloaddition Reactions (3 papers), Fluorine in Organic Chemistry (3 papers), Synthesis and Reactions of Organic Compounds (3 papers) and Quinazolinone synthesis and applications (2 papers). The work is most often cited by research in Cell Biology (336 citations), Oncology (280 citations), Organic Chemistry (324 citations), Molecular Biology (385 citations) and Toxicology (15 citations). Frédéric Jung has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Nicola M. Heron, Andrew Mortlock, Stephen Green, Robert W. Wilkinson, Nicholas Keen, Kevin M. Foote, Tony Durst, Stephen R. Wedge, Rajesh Odedra and Madeleine C. Brady. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Tetrahedron, Journal of the American Chemical Society and Current Topics in Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Frédéric Jung

Impact in

Papers in i

In The Last Decade

Frédéric Jung

Peers

Countries citing papers authored by Frédéric Jung

Fields of papers citing papers by Frédéric Jung

All Works

About Frédéric Jung

Explore authors with similar magnitude of impact

Papers in